Who
Phyllis R. Yale
Director
Company insider
Files Form 4 as: Director, Bristol-Myers Squibb; Director, DaVita; Director, Kindred Healthcare; Director, Pediatric Services Of America.
In numbers
- Trades disclosed
- 113
- Buys
- 1
- Sells
- 2
- Bought
- $103K
- Sold
- $837K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 31 Aug 2007
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K560.897 at $62.40 | filing |
| 15 Aug 2026filed 18 Aug 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —278 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —278 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K607.428 at $57.62 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K607.43 at $57.62 | filing |
| 26 May 2026filed 28 May 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code G | —5,038 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code G | —5,038 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K577.082 at $60.65 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K577.08 at $60.65 | filing |
| 15 Mar 2026filed 17 Mar 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —332 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —332 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K3,996.367 at $55.05 | filing |
| 1 Feb 2026filed 3 Feb 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K3,996.37 at $55.05 | filing |
| 31 Dec 2025filed 5 Jan 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —648.869 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —648.87 at $0.00 | filing |
| 15 Nov 2025filed 17 Nov 2025 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —411 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —776.05 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —369 at $0.00 | filing |
News
7,152 Shares of DaVita Inc. $DVA Purchased by Westwind CapitalDVA · dailypolitical.com · 9 Oct 2026
0 headlines in the last 90 days name Phyllis R. Yale; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.